Accessibility Tools

Healthcare News

  • Clinical Trial: Oral Drug Could Treat Uterine Fibroid Bleeding and the Fibroids Themselves

    A new drug that targets both heavy bleeding caused by uterine fibroids and the fibroids themselves has shown promise in clinical trials.The drug, called linzagolix and prescribed under the brand name Yselty in Europe, is administered orally and can be dosed according to a patient’s exact needs.

    Read more

  • Menstrual Bleeding Changes Reported After COVID-19 Vaccination

    42 percent of those with regular menstrual cycles bled more heavily than usual after COVID-19 vaccination

    Read more

  • Review finds hysterectomy can be avoided for common gynecological condition

    Adenomyosis—an abnormal tissue growth into the muscular wall of the uterus that causes painful cramps and heavy or prolonged menstrual bleeding—is more common than generally appreciated, a review of the literature by gynecologists at UT Southwestern Medical Center revealed. The researchers identify several medical therapies and uterine-sparing procedures that can effectively improve symptoms without need for a hysterectomy.

    Read more

  • New study finds no risk of pregnancy loss from COVID-19 vaccination

    Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the results of a study published in Osteoporosis International that demonstrate a decrease, and in some cases elimination of oral opioids, and decrease in payer costs following balloon kyphoplasty (BKP) or vertebroplasty (VP) procedures in patients suffering from spinal fractures, known as vertebral compression fractures (VCF).

    Read more

  • Study: One in six women with endometriosis have lost jobs due to the condition

    Researchers from Southern Cross University's National Centre for Naturopathic Medicine and Western Sydney University 's NICM Health Research Institute have conducted a national survey of 389 women with a confirmed diagnosis of endometriosis, finding that with 1 in 3 (31 percent) women with endometriosis reporting being passed over for promotion due to having to manage their endometriosis symptoms, and 1 in 6 (15 percent) women reporting being fired due to having to manage their endometriosis symptoms.

    Read more